| Website | oxitec.com |
| Category | Other |
| Phone | +44 (0)1235 832393 |
| Employees |
| TOTAL | $13M |
| VENTURE FUNDING TOTAL | $13M |
| Venture Round, 2/12 Oxford Capital Partners | £8M |
Oxitec is developing and commercialising an effective and environment-friendly proprietary technology for the control of significant insect pests. Oxitec’s technology has the potential to make a major contribution for both global health and agriculture by combating insects responsible for serious diseases such as dengue fever as well as agricultural damage. The proprietary technology builds on inventions from the University of Oxford and employs genetics and molecular biology to enhance the cost-effectiveness and safety of the existing Sterile Insect Technique (SIT), and to extend SIT to a broader range of insect pests.
